Closed petition: Fund access to GLP-1 medications through the NHS for women with PCOS
Closed on
Studies highlight the effectiveness of GLP-1 medications for women with PCOS. We think funding access to GLP-1 treatments, without restrictive BMI criteria or tier system barriers, would improve care and outcomes for these patients.
Studies reveal that women with PCOS have higher absenteeism, increased unemployment, and a greater risk of disability retirement by age 52.
Without effective preventive treatments like GLP-1, we think there is a greater burden on the NHS due to downstream complications of untreated PCOS later on. This can include diabetes, cardiovascular disease, infertility, mental health issues, and cancer.
We think early intervention is essential to reduce these long-term healthcare costs on the NHS.
840 signatures
Petition progress
View all updates for this petition, with the most recent first.
-
Petition closed
-
Related activity
-
Petition published
This petition can now be signed.
If this petition gets 10,000 signatures, government will respond to it.
If this petition gets 100,000 signatures, it will be considered for debate in Parliament.
This petition will stay open until 14 July 2025.